teva pharmaceuticals introduces the first generic glp-1 for weight loss wins US obesity approval its liraglutide | News Teva Launches First Generic GLP-1

(1990): Evaluation of the effects of L-acetylcarnitine on senile patients suffering from depression

Due to the fact that GLP-1 acting drugs such as dulaglutide, liraglutide, and semaglutide do not need dosage adjustments for patients with renal impairment, these medications are considered to be the most recommended choices for patients who have chronic kidney disease (Zheng et al

6(1):30-9 Basic mechanisms involved in the anti-cancer effects of melatonin Mediavilla MD,et al Curr Med Chem 2010

Maitra, I., Serbinova, E., Trischler, H., and Packer, L

Sci World J Vol 2013

Additionally, increasing government initiatives focused on obesity management and supportive regulatory frameworks are facilitating faster drug approvals and market penetration